Oppenheimer Asset Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.94M | Sell |
4,108
-662
| -14% | -$333K | 0.02% | 555 |
|
|
2025
Q4 | $2.23M | Sell |
4,770
-1,043
| -18% | -$484K | 0.03% | 484 |
|
|
2025
Q3 | $2.48M | Buy |
5,813
+1,659
| +40% | +$643K | 0.03% | 511 |
|
|
2025
Q2 | $1.59M | Sell |
4,154
-160
| -4% | -$57.7K | 0.02% | 626 |
|
|
2025
Q1 | $1.49M | Buy |
4,314
+105
| +2% | +$33.8K | 0.02% | 616 |
|
|
2024
Q4 | $1.26M | Buy |
4,209
+125
| +3% | +$43.7K | 0.02% | 660 |
|
|
2024
Q3 | $1.66M | Sell |
4,084
-58
| -1% | -$21.2K | 0.02% | 594 |
|
|
2024
Q2 | $1.33M | Sell |
4,142
-3,291
| -44% | -$1.07M | 0.02% | 644 |
|
|
2024
Q1 | $2.48M | Sell |
7,433
-467
| -6% | -$143K | 0.04% | 429 |
|
|
2023
Q4 | $2.14M | Sell |
7,900
-273
| -3% | -$67.5K | 0.03% | 495 |
|
|
2023
Q3 | $2.01M | Sell |
8,173
-26
| -0.3% | -$7.11K | 0.03% | 493 |
|
|
2023
Q2 | $2.49M | Sell |
8,199
-1,662
| -17% | -$462K | 0.04% | 445 |
|
|
2023
Q1 | $2.6M | Sell |
9,861
-337
| -3% | -$85.6K | 0.04% | 424 |
|
|
2022
Q4 | $2.45M | Buy |
10,198
+79
| +0.8% | +$17.7K | 0.04% | 425 |
|
|
2022
Q3 | $1.86M | Sell |
10,119
-362
| -3% | -$72.1K | 0.03% | 468 |
|
|
2022
Q2 | $1.76M | Buy |
10,481
+2,467
| +31% | +$530K | 0.03% | 505 |
|
|
2022
Q1 | $2.01M | Buy |
8,014
+1,800
| +29% | +$452K | 0.03% | 528 |
|
|
2021
Q4 | $1.6M | Hold |
6,214
| – | – | 0.02% | 623 |
|
|
2021
Q3 | $1.51M | Sell |
6,214
-197
| -3% | -$48.2K | 0.02% | 619 |
|
|
2021
Q2 | $1.33M | Sell |
6,411
-1,278
| -17% | -$260K | 0.02% | 667 |
|
|
2021
Q1 | $1.45M | Buy |
7,689
+163
| +2% | +$28.7K | 0.02% | 614 |
|
|
2020
Q4 | $1.24M | Sell |
7,526
-3
| -0% | -$439 | 0.02% | 616 |
|
|
2020
Q3 | $939K | Buy |
7,529
+290
| +4% | +$35.9K | 0.02% | 634 |
|
|
2020
Q2 | $702K | Buy |
7,239
+202
| +3% | +$21K | 0.01% | 703 |
|
|
2020
Q1 | $632K | Sell |
7,037
-110
| -2% | -$14.2K | 0.02% | 669 |
|
|
2019
Q4 | $1.06M | Sell |
7,147
-133
| -2% | -$17.9K | 0.02% | 610 |
|
|
2019
Q3 | $877K | Buy |
7,280
+833
| +13% | +$108K | 0.02% | 653 |
|
|
2019
Q2 | $872K | Buy |
6,447
+272
| +4% | +$34.4K | 0.02% | 657 |
|
|
2019
Q1 | $805K | Buy |
6,175
+17
| +0.3% | +$2.28K | 0.02% | 661 |
|
|
2018
Q4 | $767K | Sell |
6,158
-14
| -0.2% | -$1.88K | 0.02% | 644 |
|
|
2018
Q3 | $859K | Buy |
6,172
+325
| +6% | +$40.5K | 0.02% | 654 |
|
|
2018
Q2 | $600K | Buy |
5,847
+150
| +3% | +$15.2K | 0.01% | 743 |
|
|
2018
Q1 | $553K | Buy |
+5,697
| New | +$553K | 0.01% | 763 |
|
|
2017
Q4 | – | Sell |
-789
| Closed | -$63K | – | 1235 |
|
|
2017
Q3 | $63K | Buy |
789
+254
| +47% | +$20.4K | ﹤0.01% | 1311 |
|
|
2017
Q2 | $46K | Sell |
535
-111
| -17% | -$9.39K | ﹤0.01% | 1363 |
|
|
2017
Q1 | $58K | Buy |
+646
| New | +$53.9K | ﹤0.01% | 1308 |
|
Other funds holding HCA
VCM
VPM
Oppenheimer Asset Management's HCA Position: Q1 2026 in Review
Oppenheimer Asset Management reduced its HCA Healthcare (HCA) stake by 14% in Q1 2026, selling an estimated $333K and leaving 4,108 shares worth $1.94M. The position accounts for 0.02% of the portfolio, ranked #555.
Oppenheimer Asset Management first reported a position in HCA in Q1 2017 and has held it in 36 quarters since. The position peaked at $2.6M in Q1 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Oppenheimer Asset Management held 4,108 shares of HCA Healthcare worth $1.94M as of Q1 2026.
- Oppenheimer Asset Management sold 662 HCA Healthcare shares in Q1 2026, an estimated $333K.
- HCA Healthcare made up 0.02% of Oppenheimer Asset Management's portfolio in Q1 2026, its #555 holding.
- Oppenheimer Asset Management first reported a position in HCA Healthcare in Q1 2017 and has held it in 36 quarters since.
- Oppenheimer Asset Management's HCA Healthcare position peaked at $2.6M in Q1 2023.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.